Orthopaedic specialist Stryker has said it is “disappointed” by accusations charging the company's biotech division of improper marketing practices and intentionally defrauding the FDA. An indictment made by the federal grand jury in the District of Massachusetts against Stryker ...
Please Login to read the full article.
